"Hemangiopericytoma is an Indolent, But Lethal Mesenchymal Tumor: A Clinical Outcomes Based Study of 789 Patients From the Surveillance Epidemiology and End Result (SEER) Database" by P. Sridharan

Selected Works of Ronald Chamberlain, MD, MPA, FACS

Article

Hemangiopericytoma is an Indolent, But Lethal Mesenchymal Tumor: A Clinical Outcomes Based Study of 789 Patients From the Surveillance Epidemiology and End Result (SEER) Database

Journal of Surgical Research (2013)

P. Sridharan, Saint Barnabas Medical Center
S. Patil, Saint Barnabas Medical Center
R.S. Chamberlain, Saint Barnabas Medical Center

Link

Disciplines

Medicine and Health Sciences,
Oncology,
Pathology,
Epidemiology and
Internal Medicine

Publication Date

February 1, 2013

DOI

10.1016/J.JSS.2012.10.607

Citation Information

P. Sridharan, S. Patil and R.S. Chamberlain. "Hemangiopericytoma is an Indolent, But Lethal Mesenchymal Tumor: A Clinical Outcomes Based Study of 789 Patients From the Surveillance Epidemiology and End Result (SEER) Database" Journal of Surgical Research Vol. 179 Iss. 2 (2013) p. 304
Available at: http://works.bepress.com/ronald-chamberlain/113/